Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 839,"Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5.",body mass,,RS:0000199,DA.ACI-(D10Rat2-D10Rat29)/Kini,male,131 days to 103 days,10,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,1.2,%,1.1384,3.6,MMO:0000016,body weighing method,,0.0,from before p.i.,intradermal injection,40,days,myelin oligodendrocyte glycoprotein (20 ug) ,68720,myelin oligodendrocyte glycoprotein (20 ug) 839,"Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5.",body mass,,RS:0000199,DA.ACI-(D10Rat2-D10Rat29)/Kini,male,131 days to 103 days,10,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,0,%,0.0,0.0,MMO:0000016,body weighing method,,0.0,from before p.i.,intradermal injection,40,days,myelin oligodendrocyte glycoprotein (20 ug) ,68723,myelin oligodendrocyte glycoprotein (20 ug) 839,"Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5.",body mass,,RS:0000199,DA.ACI-(D10Rat2-D10Rat29)/Kini,male,131 days to 103 days,8,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,0,%,0.0,0.0,MMO:0000016,body weighing method,,0.0,from before p.i.,intradermal injection,40,days,myelin oligodendrocyte glycoprotein (20 ug) ,68725,myelin oligodendrocyte glycoprotein (20 ug) 839,"Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5.",body mass,,RS:0000199,DA.ACI-(D10Rat2-D10Rat29)/Kini,male,131 days to 103 days,7,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,0,%,0.0,0.0,MMO:0000016,body weighing method,,0.0,from before p.i.,intradermal injection,40,days,myelin oligodendrocyte glycoprotein (20 ug) ,68728,myelin oligodendrocyte glycoprotein (20 ug)